Maya Deepti Srinivasan, MD
Clinical Instructor, Hematology & Oncology
Biography
I am a third-year clinical fellow in Hematology & Medical Oncology at the Boston Medical Center (BMC) and a Clinical Instructor at the Boston University Chobanian & Avedisian School of Medicine (BUSM). Under the clinical and research mentorship of Dr. J Mark Sloan, I have developed an interest in dedicating to the clinical care of patients with virally-mediated (HTLV-, EBV-, and HIV- associated) lymphomas. My clinical research activities are focused on improving access to clinical trials and identifying tolerable and effective regimens for patients with demonstrable biological rationale for patients with Adult T-cell Leukemia/Lymphoma (ATLL). I deeply seek to improve outcomes for patients and families impacted by HTLV/ATLL.
Prior to fellowship, I have spent the entirety of my clinical training in safety-net settings. After internal medicine residency at SUNY Downstate Medical Center/Kings County Hospital Center, I completed a chief residency year. I focused my chief residency year on improving access to outpatient cancer screening for safety-net patients and establishing a mentoring program for trainees.
Websites
Publications
- Published on 11/5/2024
Srinivasan MD, Dittus C, El-Jawahri A, Jain S, Shelton A, Sloan JM. Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL). Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL). 2024; 144(Blood):6405.
Read at: Custom - Published on 11/5/2024
Bodanapu G, Corrigan J, Culnan J, Srinivasan M, Hora M, Lazzaro A, Yildirim C, Elbers D, Lang D, Do N, Brophy M, Bell B, Szalat RE, Munshi NC, Fillmore NR, Edwards CV. Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems. Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems. 2024; 144(Blood):3341.
Read at: Custom - Published on 12/14/2020
Saggi SJ, Nath S, Culas R, Chittalae S, Burza A, Srinivasan M, Abdul R, Silver B, Lora A, Ibtida I, Chokshi T, Capric V, Mohamed A, Worah S, OuYang J, Geraghty P, Gruessner A, Salifu MO. Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis. Clin Med Insights Circ Respir Pulm Med. 2020; 14:1179548420980699. PMID: 33402859.
Read at: PubMed